PubMed

Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation.

Ridker PM, Glynn RJ, Miletich JP, Goldhaber SZ, Stampfer MJ, Hennekens CH.

Ann Intern Med. 1997 Apr 1;126(7):528-31.PMID: 9092318 [PubMed - indexed for MEDLINE]Related articlesFree article

Factor V Leiden and risks of recurrent idiopathic venous thromboembolism.

Ridker PM, Miletich JP, Stampfer MJ, Goldhaber SZ, Lindpaintner K, Hennekens CH.

Circulation. 1995 Nov 15;92(10):2800-2.PMID: 7586244 [PubMed - indexed for MEDLINE]Related articlesFree article

A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism.

Middeldorp S, Meinardi JR, Koopman MM, van Pampus EC, Hamulyák K, van Der Meer J, Prins MH, Büller HR.

Ann Intern Med. 2001 Sep 4;135(5):322-7.PMID: 11529695 [PubMed - indexed for MEDLINE]Related articlesFree article

The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis.

Middeldorp S, Henkens CM, Koopman MM, van Pampus EC, Hamulyák K, van der Meer J, Prins MH, Büller HR.

Ann Intern Med. 1998 Jan 1;128(1):15-20.PMID: 9424976 [PubMed - indexed for MEDLINE]Related articlesFree article

Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study.

Simioni P, Tormene D, Prandoni P, Zerbinati P, Gavasso S, Cefalo P, Girolami A.

Blood. 2002 Mar 15;99(6):1938-42.PMID: 11877263 [PubMed - indexed for MEDLINE]Related articlesFree article

The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden).

Simioni P, Prandoni P, Lensing AW, Scudeller A, Sardella C, Prins MH, Villalta S, Dazzi F, Girolami A.

N Engl J Med. 1997 Feb 6;336(6):399-403.PMID: 9010145 [PubMed - indexed for MEDLINE]Related articlesFree article

The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.

De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G.

N Engl J Med. 1999 Sep 9;341(11):801-6.PMID: 10477778 [PubMed - indexed for MEDLINE]Related articlesFree article

Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism.

Rodeghiero F, Tosetto A.

Ann Intern Med. 1999 Apr 20;130(8):643-50.PMID: 10215560 [PubMed - indexed for MEDLINE]Related articlesFree article

Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening.

Ridker PM, Miletich JP, Hennekens CH, Buring JE.

JAMA. 1997 Apr 23-30;277(16):1305-7.PMID: 9109469 [PubMed - indexed for MEDLINE]Related articles

Factor V Leiden and the risk for venous thromboembolism in the adult Danish population.

Juul K, Tybjaerg-Hansen A, Schnohr P, Nordestgaard BG.

Ann Intern Med. 2004 Mar 2;140(5):330-7.PMID: 14996674 [PubMed - indexed for MEDLINE]Related articlesFree article

The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.

Eichinger S, Weltermann A, Mannhalter C, Minar E, Bialonczyk C, Hirschl M, Schönauer V, Lechner K, Kyrle PA.

Arch Intern Med. 2002 Nov 11;162(20):2357-60.PMID: 12418950 [PubMed - indexed for MEDLINE]Related articlesFree article

The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both.

Martinelli I, Bucciarelli P, Margaglione M, De Stefano V, Castaman G, Mannucci PM.

Br J Haematol. 2000 Dec;111(4):1223-9.PMID: 11167765 [PubMed - indexed for MEDLINE]Related articles

Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden.

Rintelen C, Mannhalter C, Ireland H, Lane DA, Knöbl P, Lechner K, Pabinger I.

Br J Haematol. 1996 May;93(2):487-90.PMID: 8639453 [PubMed - indexed for MEDLINE]Related articles

Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation.

Manten B, Westendorp RG, Koster T, Reitsma PH, Rosendaal FR.

Thromb Haemost. 1996 Oct;76(4):510-3.PMID: 8902987 [PubMed - indexed for MEDLINE]Related articles

Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism.

Ridker PM, Hennekens CH, Selhub J, Miletich JP, Malinow MR, Stampfer MJ.

Circulation. 1997 Apr 1;95(7):1777-82.PMID: 9107163 [PubMed - indexed for MEDLINE]Related articlesFree article

Probability of recurrence of thrombosis in patients with and without factor V Leiden.

Rintelen C, Pabinger I, Knöbl P, Lechner K, Mannhalter C.

Thromb Haemost. 1996 Feb;75(2):229-32.PMID: 8815565 [PubMed - indexed for MEDLINE]Related articles

Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis.

Meinardi JR, Middeldorp S, de Kam PJ, Koopman MM, van Pampus EC, Hamulyák K, Prins MH, Büller HR, van der Meer J.

Blood Coagul Fibrinolysis. 2001 Dec;12(8):713-20.PMID: 11734673 [PubMed - indexed for MEDLINE]Related articles

Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men.

Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP.

N Engl J Med. 1995 Apr 6;332(14):912-7.PMID: 7877648 [PubMed - indexed for MEDLINE]Related articlesFree article

G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism.

Miles JS, Miletich JP, Goldhaber SZ, Hennekens CH, Ridker PM.

J Am Coll Cardiol. 2001 Jan;37(1):215-8.PMID: 11153741 [PubMed - indexed for MEDLINE]Related articles

Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.

Price DT, Ridker PM.

Ann Intern Med. 1997 Nov 15;127(10):895-903. Review.PMID: 9382368 [PubMed - indexed for MEDLINE]Related articlesFree article